send to a friend by email
2021-11-01
According to financial statements of Jerusalem Pharmaceuticals JPH for the first nine months of 2021, Net profit after tax of the period reached 2,698,334 USD Compared with Net profit after tax 2,602,689 USD for 2020, a net increase in profit of 3.67%.Total assets of the company reached 81,388,899 USD compared with total assets of 77,707,289 USD at the end of year 2020, a net increase of 4.74%.Total liabilities of the company reached 18,693,217 USD compared with total liabilities of 16,066,093 USD at the end of year 2020, a net increase of 16.35%. Net ownership equity of the company reached 62,695,682 USD (Including Non-Controlling Interests of 2,208,282 USD) compared with total owner equity of 61,641,196 USD (Including Non-Controlling Interests of 2,318,984 USD) at the end of year 2020, a net increase of 1.71%.
|
|